These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27001307)

  • 1. Intercellular Communication between Keratinocytes and Fibroblasts Induces Local Osteoclast Differentiation: a Mechanism Underlying Cholesteatoma-Induced Bone Destruction.
    Iwamoto Y; Nishikawa K; Imai R; Furuya M; Uenaka M; Ohta Y; Morihana T; Itoi-Ochi S; Penninger JM; Katayama I; Inohara H; Ishii M
    Mol Cell Biol; 2016 Jun; 36(11):1610-20. PubMed ID: 27001307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma.
    Gong N; Zhu W; Xu R; Teng Z; Deng C; Zhou H; Xia M; Zhao M
    Biochem Biophys Res Commun; 2020 Apr; 525(2):341-347. PubMed ID: 32093888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
    Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
    Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis.
    Bloemen V; Schoenmaker T; de Vries TJ; Everts V
    J Cell Physiol; 2010 Mar; 222(3):565-73. PubMed ID: 19927302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling.
    Imai R; Sato T; Iwamoto Y; Hanada Y; Terao M; Ohta Y; Osaki Y; Imai T; Morihana T; Okazaki S; Oshima K; Okuzaki D; Katayama I; Inohara H
    J Assoc Res Otolaryngol; 2019 Oct; 20(5):449-459. PubMed ID: 31254133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DGKζ Downregulation Enhances Osteoclast Differentiation and Bone Resorption Activity Under Inflammatory Conditions.
    Iwazaki K; Tanaka T; Hozumi Y; Okada M; Tsuchiya R; Iseki K; Topham MK; Kawamae K; Takagi M; Goto K
    J Cell Physiol; 2017 Mar; 232(3):617-624. PubMed ID: 27312515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state.
    Nakayachi M; Ito J; Hayashida C; Ohyama Y; Kakino A; Okayasu M; Sato T; Ogasawara T; Kaneda T; Suda N; Sawamura T; Hakeda Y
    Bone; 2015 Jun; 75():170-82. PubMed ID: 25744064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher degree of keratinization correlated with severe bone destruction in acquired Cholesteatoma.
    Feng Y; Li Z; He W; Xiong Y; Si Y; Zhang Z
    Acta Otolaryngol; 2023 Feb; 143(2):147-155. PubMed ID: 36883320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
    Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis.
    Suematsu A; Tajiri Y; Nakashima T; Taka J; Ochi S; Oda H; Nakamura K; Tanaka S; Takayanagi H
    Mod Rheumatol; 2007; 17(1):17-23. PubMed ID: 17278017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK promotes osteoclastogenesis in rheumatoid arthritis.
    Park JS; Kwok SK; Lim MA; Oh HJ; Kim EK; Jhun JY; Ju JH; Park KS; Park YW; Park SH; Kim HY; Cho YG; Cho ML
    Am J Pathol; 2013 Sep; 183(3):857-67. PubMed ID: 23845567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.